{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-009854","form_type":"8-K","ticker":"DFTX","cik":"0001813814","company_name":"Definium Therapeutics, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.274718+00:00","generated_at":"2026-05-16T10:55:56.193085+00:00","sec_items":["2.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"MindMed rebrands to Definium Therapeutics; $412M cash; three Phase 3 readouts in 2026","bullets":["Preliminary cash and investments ~$412M as of Dec 31, 2025.","Name changed to Definium Therapeutics; new ticker DFTX effective Jan 13.","Three Phase 3 readouts for DT120 ODT (GAD/MDD) in 2026: Voyage (2Q), Panorama (2H), Emerge (mid-year).","Analyst Day in 2Q 2026 to highlight pipeline and path to commercialization.","DT402 Phase 2a for autism spectrum disorder dosed first patient; initial data in 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-009854","json":"https://secwatch.observer/filing/0001193125-26-009854.json","markdown":"https://secwatch.observer/filing/0001193125-26-009854.md","text":"https://secwatch.observer/filing/0001193125-26-009854.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526009854/0001193125-26-009854-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526009854/mnmd-20260109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:55:56.193085+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d7aa87edbf0c4cd640de4f8a02eb64b19f47e385","claim":"Definium Therapeutics, Inc.: Changed company name from Mind Medicine (MindMed) Inc. to Definium Therapeutics, Inc. via alteration of Notice of Articles (effective 2026-01-09).","evidence_excerpt":"On January 9, 2026, the Company filed a Notice of Alteration with the Province of British Columbia Registrar of Companies to alter its Notice of Articles to change the Company’s corporate name from “Mind Medicine (MindMed) Inc.” to “Definium Therapeutics, Inc.”","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526009854/0001193125-26-009854-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001185185-26-002273","ticker":"DGAC","company_name":"DISCIPLINED GROWTH ACQUISITION Corp","filed_at":"2026-06-01T20:15:34+00:00","headline":"Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-26-002273","json":"https://secwatch.observer/filing/0001185185-26-002273.json","markdown":"https://secwatch.observer/filing/0001185185-26-002273.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/dgac8k052926.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Notice of Alteration with the Province of British Columbia Registrar of Companies to alter its Notice of Articles to change the Company’s corporate name from “Mind Medicine (MindMed) Inc.” to “Definium Therapeutics, Inc.”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526009854/0001193125-26-009854-index.htm","comparable_excerpt":"On May 26, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 26, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm"}},{"accession":"0001104659-26-068521","ticker":"FDXF","company_name":"FedEx Freight Holding Company, Inc.","filed_at":"2026-06-01T10:46:03+00:00","headline":"FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed","event_type":"other_material","sec_items":["1.01","2.03","3.03","5.03","5.01","5.02","5.05","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068521","json":"https://secwatch.observer/filing/0001104659-26-068521.json","markdown":"https://secwatch.observer/filing/0001104659-26-068521.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/0001104659-26-068521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/tm2615735d2_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Notice of Alteration with the Province of British Columbia Registrar of Companies to alter its Notice of Articles to change the Company’s corporate name from “Mind Medicine (MindMed) Inc.” to “Definium Therapeutics, Inc.”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526009854/0001193125-26-009854-index.htm","comparable_excerpt":"As of 9:30 a.m., Eastern Time, on May 27, 2026, the certificate of incorporation of the Company was amended by the certificate of amendment to the certificate of incorporation of the Company (the “Certificate of Amendment”), which, among other things, (i) created and authorized 500,000,000 shares of the Company’s common stock, par value $0.10 per share (the “Common Stock”), and (ii) converted the total number of shares of the Common Stock issued and outstanding into a number of validly issued, fully paid, and non-assessable shares of the Common Stock authorized for issuance pursuant to the Certificate of Amendment equal to 149,505,248.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/0001104659-26-068521-index.htm"}},{"accession":"0001193125-26-245505","ticker":"PRHI","company_name":"Presurance Holdings, Inc.","filed_at":"2026-05-28T21:10:02+00:00","headline":"Presurance Holdings announces 1-for-7 reverse stock split to meet Nasdaq listing requirements","event_type":"other_material","sec_items":["3.03","5.03","7.01","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-245505","json":"https://secwatch.observer/filing/0001193125-26-245505.json","markdown":"https://secwatch.observer/filing/0001193125-26-245505.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1502292/000119312526245505/0001193125-26-245505-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1502292/000119312526245505/prhi-20260528.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Notice of Alteration with the Province of British Columbia Registrar of Companies to alter its Notice of Articles to change the Company’s corporate name from “Mind Medicine (MindMed) Inc.” to “Definium Therapeutics, Inc.”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526009854/0001193125-26-009854-index.htm","comparable_excerpt":"On May 28, 2026, the Company filed with the Secretary of State of the State of Michigan (the “Michigan Secretary of State”) a Certificate of Amendment to its Articles of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1502292/000119312526245505/0001193125-26-245505-index.htm"}},{"accession":"0001499275-26-000012","ticker":"GROO","company_name":"GROOVY COMPANY, INC.","filed_at":"2026-05-28T15:05:37+00:00","headline":"Groovy Company rescinds entire prior 8-K filed May 13, 2026; no reliance advised","event_type":"other_material","sec_items":["4.01","5.02","5.03","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001499275-26-000012","json":"https://secwatch.observer/filing/0001499275-26-000012.json","markdown":"https://secwatch.observer/filing/0001499275-26-000012.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1499275/000149927526000012/0001499275-26-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1499275/000149927526000012/groo-20250813_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Notice of Alteration with the Province of British Columbia Registrar of Companies to alter its Notice of Articles to change the Company’s corporate name from “Mind Medicine (MindMed) Inc.” to “Definium Therapeutics, Inc.”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526009854/0001193125-26-009854-index.htm","comparable_excerpt":"ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR. The Registrant hereby rescinds and withdraws all disclosures contained in Item 5.03 of the Prior Form 8-K.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1499275/000149927526000012/0001499275-26-000012-index.htm"}},{"accession":"0001213900-26-061493","ticker":"OHAC","company_name":"Oceanhawk Acquisition Corp.","filed_at":"2026-05-27T20:01:23+00:00","headline":"Oceanhawk Acquisition Corp. closes upsized $160M IPO of 16M units at $10/unit","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-061493","json":"https://secwatch.observer/filing/0001213900-26-061493.json","markdown":"https://secwatch.observer/filing/0001213900-26-061493.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2090787/000121390026061493/0001213900-26-061493-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2090787/000121390026061493/ea0292099-8k_oceanhawk.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Notice of Alteration with the Province of British Columbia Registrar of Companies to alter its Notice of Articles to change the Company’s corporate name from “Mind Medicine (MindMed) Inc.” to “Definium Therapeutics, Inc.”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526009854/0001193125-26-009854-index.htm","comparable_excerpt":"On May 20, 2026, the Company filed its Amended and Restated Memorandum and Articles of Association in the Cayman Islands.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2090787/000121390026061493/0001213900-26-061493-index.htm"}},{"accession":"0001213900-26-061252","ticker":"HOTH","company_name":"Hoth Therapeutics, Inc.","filed_at":"2026-05-27T12:33:47+00:00","headline":"Hoth Therapeutics renames to Rocket One Inc.; ticker changes to RKTO, pivots to space AI chip tech","event_type":"other_material","sec_items":["5.03","8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-061252","json":"https://secwatch.observer/filing/0001213900-26-061252.json","markdown":"https://secwatch.observer/filing/0001213900-26-061252.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711786/000121390026061252/0001213900-26-061252-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711786/000121390026061252/ea0292213-8k_rocket.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Notice of Alteration with the Province of British Columbia Registrar of Companies to alter its Notice of Articles to change the Company’s corporate name from “Mind Medicine (MindMed) Inc.” to “Definium Therapeutics, Inc.”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526009854/0001193125-26-009854-index.htm","comparable_excerpt":"On May 20, 2026, Rocket One Inc. (formerly, Hoth Therapeutics, Inc.) (the “Company”) filed a Certificate of Amendment to its Articles of Incorporation, as amended (the “Charter Amendment”), with the Secretary of State of the State of Nevada to change the name of the Company from “Hoth Therapeutics, Inc.” to “Rocket One Inc.” effective as of May 26, 2026 (the “Name Change”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1711786/000121390026061252/0001213900-26-061252-index.htm"}},{"accession":"0001628280-26-038219","ticker":"LCLN","company_name":"Lincoln International, Inc.","filed_at":"2026-05-26T21:19:13+00:00","headline":"Lincoln International completes IPO of 24.2M shares at $20.00, raising $473.7M in gross proceeds","event_type":"other_material","sec_items":["1.01","3.02","3.03","5.03","5.02","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-038219","json":"https://secwatch.observer/filing/0001628280-26-038219.json","markdown":"https://secwatch.observer/filing/0001628280-26-038219.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1925283/000162828026038219/0001628280-26-038219-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1925283/000162828026038219/lincolninternational-closi.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Notice of Alteration with the Province of British Columbia Registrar of Companies to alter its Notice of Articles to change the Company’s corporate name from “Mind Medicine (MindMed) Inc.” to “Definium Therapeutics, Inc.”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526009854/0001193125-26-009854-index.htm","comparable_excerpt":"On May 19, 2026, the Company’s Amended and Restated Certificate of Incorporation (the “ Charter ”), in the form previously filed as Exhibit 3.2 to the Registration Statement, and the Company’s Amended and Restated Bylaws (the “ Bylaws ”), in the form previously filed as Exhibit 3.4 to the Registration Statement, became effective.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1925283/000162828026038219/0001628280-26-038219-index.htm"}},{"accession":"0001213900-26-060674","ticker":"APUR","company_name":"Aperture AC","filed_at":"2026-05-22T21:25:16+00:00","headline":"Aperture AC closes $102M SPAC IPO; 10.2M units at $10 each, trust funded with $102.3M","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-060674","json":"https://secwatch.observer/filing/0001213900-26-060674.json","markdown":"https://secwatch.observer/filing/0001213900-26-060674.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2093524/000121390026060674/0001213900-26-060674-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2093524/000121390026060674/ea0291975-8k_aperture.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On January 9, 2026, the Company filed a Notice of Alteration with the Province of British Columbia Registrar of Companies to alter its Notice of Articles to change the Company’s corporate name from “Mind Medicine (MindMed) Inc.” to “Definium Therapeutics, Inc.”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312526009854/0001193125-26-009854-index.htm","comparable_excerpt":"On May 22, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 20, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2093524/000121390026060674/0001213900-26-060674-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}